Adheris Health Limited (ASX: AHE) - Share Price
- Current share price for AHE : $0.012
Adheris Health Limited (AHE, formerly Medadvisor Limited) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It , is a pharmacy-driven patient engagement solution that provides personalised patient experiences to help simplify the patient medication journey.
AHE General Information +
| ASX Code | AHE |
| Website | http://adheris.com/investors |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 7 |
| AHE Share Price | $0.012 |
| Day High | $0.012 |
| Day Low | $0.012 |
| Last Close | $0.012 |
| AHE Share Price Movement | - ( No change ) |
Prices as at 16:41, 29 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Adheris Health Limited (AHE) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| Result | 9¢ | 100% | 12 Mar 2015 | 2 Apr 2015 | - | - | - |
| HFResult | 12.5¢ | 100% | 10 Sep 2014 | 2 Oct 2014 | - | - | - |
| Interim | 8.5¢ | 100% | 12 Mar 2014 | 3 Apr 2014 | - | - | - |
See all dividends from Adheris Health Limited (AHE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Adheris Health Limited (AHE) price-sensitive announcements
AHE - Adheris Health legal claim
Adheris Health Limited, trading on ASX as AHE, is engaged in a legal dispute with Mindspri
Adheris Health Limited (AHE)
31 Jul 2026 | 3:32 PM
31 Jul 2026 | 3:32 PM
AHE - 4Q FY26 Quarterly Activity Report and Appendix 4C
Adheris Health Limited, an Australian company, reported a significant decrease in revenue
Adheris Health Limited (AHE)
23 Jul 2026 | 9:20 AM
23 Jul 2026 | 9:20 AM
AHE - Q3 FY26 Results Presentation
Adheris Health Limited reported its Q3 FY26 financial results, showing a revenue of $5.4 m
Adheris Health Limited (AHE)
29 Apr 2026 | 8:45 AM
29 Apr 2026 | 8:45 AM
AHE - 3Q FY26 Quarterly Activity Report and Appendix 4C
Adheris Health Limited reported its Q3 FY26 results, showing a decline in operating revenu
Adheris Health Limited (AHE)
28 Apr 2026 | 8:42 AM
28 Apr 2026 | 8:42 AM
Adheris Health Limited (AHE) Recent ASX Announcements
AHE Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$19.97 | -$3.20 | 6.10% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$16.78 | -$3.00 | -2,384.60% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | $0.79 | $0.10 | -106.30% | 203.50 | 0.00 | 0.00% | 0.0% |
AHE Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| 4DMedical Limited (4DX) | $2,406M | 1.4982 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Adheris Health Limited (AHE) | $8M | 0.0606 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $623M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $16,820M | 1.3034 | -0.2811 | 0.2395 | 63.4858 | 88.3111 | 71.2452 | 0.43% | 0.57% | 0.71% |
AHE Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | -3.16 | 0.00 |
| Market | 0.34 | 13.70 | 1.16 | 0.78 |
| Sector | 0.61 | 20.60 | 1.84 | 2.51 |
AHE Directors
| Name | Position | Start Date |
|---|---|---|
| Mr John Ciccio | Chief Executive Officer, Managing Director | 7 Nov 2025 |
| Mr John Murray | Non-Executive Director | 1 Jul 2026 |
| Mr Lucas Merrow | Non-Executive Director | 10 Aug 2021 |
| Ms Catherine (Kate) Jane Hill | Non-Executive Director, Interim Chairman | 24 May 2023 |
Adheris Health Limited (AHE) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 13 May 2026 | CICCIO, John | Buy | Direct Shares | 639,459 | $0.021 | $13,428.639 |
| 11 May 2026 | CICCIO, John | Buy | Direct Shares | 323,541 | $0.021 | $6,734.859 |
| 9 Mar 2026 | MERROW, Lucas | Buy | Direct Shares | 695,000 | $0.022 | $15,116.250 |
See all changes in directors' interest & trades for Adheris Health Limited (AHE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AHE Management
| Name | Position |
|---|---|
| Ancila Desai | Chief Financial Officer |
| Lee Tamplin | Company Secretary |
AHE Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Adheris Health Limited (AHE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 94,905,130 (15.19%) | Guild Group Holdings Limited |
| 89,833,789 (14.37%) | Perennial Value Management Limited |
| 53,986,463 (8.64%) | EBOS Group Limited |
| 52,389,949 (8.38%) | Jencay Capital Pty Limited |
| 43,999,999 (7.04%) | Cotiviti Services LLC |
| 43,999,999 (7.04%) | KKR Entities |
AHE Calendar of Events
| Date | Event |
|---|---|
| 31 August 2027 | Report (Prelim) |
| 30 August 2027 | Report (Annual) |
| 30 August 2027 | Report (Prelim) |
| 26 February 2027 | Report (Interim) |
| 08 October 2026 | Report (Annual) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
